Interleukin-1β receptor antagonism prevents cognitive impairment following experimental bacterial meningitis

Current Neurovascular Research

Volumn 12, Issue 3, 2015, Pages 253-261

  Barichello, Tatiana ^a,e   Generoso, Jaqueline S ^a   Simões, Lutiana R ^a   Sharin, Vladislav G ^e   Ceretta, Renan A ^a   Dominguini, Diogo ^a   Comim, Clarissa M ^b   Vilela, Márcia C ^c   Teixeira, Antonio Lucio ^d   Quevedo, João ^a,e  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Bacterial meningitis; BDNF; Behaviour; Cytokines; Hippocampus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AVERSIVE BEHAVIOR; BEHAVIORAL RESEARCH; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HABITUATION; HIPPOCAMPUS; MALE; MEMORY; NONHUMAN; OPEN FIELD TEST; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; ANALYSIS OF VARIANCE; ANIMAL; BACTERIAL MENINGITIS; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; INHIBITION (PSYCHOLOGY); METABOLISM; PATHOGENICITY; RECOGNITION; STREPTOCOCCUS PNEUMONIAE; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; CYTOKINES; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; INHIBITION (PSYCHOLOGY); INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MENINGITIS, BACTERIAL; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); STREPTOCOCCUS PNEUMONIAE;

EID: 84937142611     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202612666150605122200     Document Type: Article

References (48)

1. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351(18): 1849-59.
2. Koppe U, Suttorp N, Opitz B. Recognition of Streptococcus Pneumoniae by the innate immune system. Cell Microbiol 2012; 14(4): 460-6.
3. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157(5): 683-94.
4. Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007; 26(22): 3214-26.
5. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13(11): 460-9.
6. Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J Infect Dis 2000; 182(5): 1437-45.
7. Shoma S, Tsuchiya K, Kawamura I, et al. Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation. Infect Immun 2008; 76(4): 1547-57.
8. Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffmann MK, Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 1989; 57(7): 1890-3.
9. Zysk G, Bruck W, Huitinga I, et al. Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol 1997; 73(1-2): 77-80.
10. Coutinho LG, Grandgirard D, Leib SL, Agnez-Lima LF. Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis. BMC Infect Dis 2013; 13: 326.
11. Mustafa MM, Ramilo O, Saez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebotreated and dexamethasone-treated patients. Am J Dis Child 1990; 144(8): 883-7.
12. Geldhoff M, Mook-Kanamori BB, Brouwer MC, et al. Inflammasome activation mediates inflammation and outcome in humans and mice with pneumococcal meningitis. BMC Infect Dis 2013; 13: 358.
13. Schmidt H, Stuertz K, Bruck W, et al. Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis. Scand J Immunol 1999; 49(5): 481-6.
14. Kastenbauer S, Koedel U, Becker BF, Pfister HW. Oxidative stress in bacterial meningitis in humans. Neurology 2002; 58(2): 186-91.
15. Grandgirard D, Steiner O, Tauber MG, Leib SL. An infant mouse model of brain damage in pneumococcal meningitis. Acta Neuropathol 2007; 114(6): 609-17.
16. Barichello T, Belarmino E, Jr., Comim CM, et al. Correlation between behavioral deficits and decreased brain-derived neurotrophic [correction of neurotrofic] factor in neonatal meningitis. J Neuroimmunol 2010; 223(1-2): 73-6.
17. Barichello T, Savi GD, Silva GZ, et al. Antibiotic therapy prevents, in part, the oxidative stress in the rat brain after meningitis induced by Streptococcus pneumoniae. Neurosci Lett 2010; 478(2): 93-6.
18. Irazuzta J, Pretzlaff RK, Zingarelli B. Caspases inhibition decreases neurological sequelae in meningitis. Crit Care Med 2008; 36(5): 1603-6.
19. Mina F, Comim CM, Dominguini D, et al. Il1-beta involvement in cognitive impairment after sepsis. Mol Neurobiol 2014; 49(2): 1069-76.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1): 265-75.
21. Kauer-Sant'Anna M, Andreazza AC, Valvassori SS, et al. A gastrin-releasing peptide receptor antagonist blocks D-amphetamineinduced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. Peptides 2007; 28(7): 1447-52.
22. Vianna MR, Alonso M, Viola H, et al. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 2000; 7(5): 333-40.
23. de Lima MN, Laranja DC, Bromberg E, Roesler R, Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res 2005; 156(1): 139-43.
24. Quevedo J, Vianna M, Zanatta MS, et al. Involvement of mechanisms dependent on NMDA receptors, nitric oxide and protein kinase A in the hippocampus but not in the caudate nucleus in memory. Behav Pharmacol 1997; 8(8): 713-7.
25. Roesler R, Schroder N, Vianna MR, et al. Differential involvement of hippocampal and amygdalar NMDA receptors in contextual and aversive aspects of inhibitory avoidance memory in rats. Brain Res 2003; 975(1-2): 207-13.
26. Izquierdo I, Barros DM, Mello e Souza T, et al. Mechanisms for memory types differ. Nature 1998; 393(6686): 635-6.
27. Barichello T, dos Santos I, Savi GD, et al. TNF-alpha, IL-1beta, IL-6, and cinc-1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J Neuroimmunol 2010; 221(1-2): 42-5.
28. Katayama T, Tanaka H, Yoshida T, Uehara T, Minami M. Neuronal injury induces cytokine-induced neutrophil chemoattractant-1 (CINC-1) production in astrocytes. J Pharmacol Sci 2009; 109(1): 88-93.
29. Barichello T, Generoso JS, Silvestre C, et al. Circulating concentrations, cerebral output of the CINC-1 and blood-brain barrier disruption in Wistar rats after pneumococcal meningitis induction. Eur J Clin Microbiol Infect Dis 2012.
30. Campbell SJ, Wilcockson DC, Butchart AG, Perry VH, Anthony DC. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem 2002; 83(2): 432-41.
31. Calkins CM, Bensard DD, Shames BD, et al. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. J Endotoxin Res 2002; 8(1): 59-67.
32. Campbell SJ, Hughes PM, Iredale JP, et al. CINC-1 is an acutephase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J 2003; 17(9): 1168-70.
33. Ballendine SA, Greba Q, Dawicki W, et al. Behavioral alterations in rat offspring following maternal immune activation and ELRCXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2015; 57: 155-65.
34. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174(5): 1209-20.
35. Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, van Furth AM. Interleukin-10 negatively regulates local cytokine and chemokine production but does not influence antibacterial host defense during murine pneumococcal meningitis. Infect Immun 2003; 71(4): 2276-9.
36. Oztuzcu S, Cakmak EA, Sivasli E, et al. Gene expression and promoter region polymorphisms of interleukin-10 in meningitis patients. Genet Test Mol Biomarkers 2011; 15(5): 327-31.
37. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003; 168(4): 476-80.
38. Schneider Soares FM, Menezes de Souza N, Liborio Schwarzbold M, et al. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation 2012; 19(6): 377-85.
39. Hergenroeder GW, Moore AN, McCoy JP, Jr., et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 2010; 7: 19.
40. Sakamoto Y, Koike K, Kiyama H, et al. A stress-sensitive chemokinergic neuronal pathway in the hypothalamo-pituitary system. Neuroscience 1996; 75(1): 133-42.
41. Yamagami S, Tamura M, Hayashi M, et al. Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J Leukoc Biol 1999; 65(6): 744-9.
42. Yamada S, Iida T, Tabata T, et al. Alcoholic fatty liver differentially induces a neutrophil-chemokine and hepatic necrosis after ischemia-reperfusion in rat. Hepatology 2000; 32(2): 278-88.
43. Hirata I, Murano M, Nitta M, et al. Estimation of mucosal inflammatory mediators in rat DSS-induced colitis. Possible role of PGE(2) in protection against mucosal damage. Digestion 2001; 1: 73-80.
44. Rachal Pugh C, Fleshner M, Watkins LR, Maier SF, Rudy JW. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev 2001; 25(1): 29-41.
45. Shieh JH, Peterson RH, Moore MA. IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies. J Immunol 1991; 147(4): 1273-8.
46. Frank MG, Barrientos RM, Thompson BM, et al. IL-1RA injected intra-cisterna magna confers extended prophylaxis against lipopolysaccharide-induced neuroinflammatory and sickness responses. J Neuroimmunol 2012; 252(1-2): 33-9.
47. Barrientos RM, Hein AM, Frank MG, Watkins LR, Maier SF. Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J Neurosci 2012; 32(42): 14641-8.
48. Leitner K, Al Shammary M, McLane M, et al. IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury. Am J Reprod Immunol 2014; 71(5): 418-26.